Piramal Alternatives, the fund management division of the Piramal Group, has invested INR 215 crore in Kolors Healthcare India, a wellness chain in South India, to support the company’s next phase of growth and expansion.

The investment has been made through Piramal Alternatives’ India Credit Opportunities Fund II (PCF II) and is aimed at strengthening Kolors Healthcare’s operational and service capabilities. The funding will support the expansion of its clinic network, enhancement of existing infrastructure, diversification of its service portfolio and the strategic transformation of its centres under the company’s ‘Kolors 2.0’ initiative.

The transaction adds to Piramal Alternatives’ track record of partnering with mid-market businesses and providing tailored capital solutions to support growth, transformation and long-term value creation.

Commenting on the investment, Kalpesh Kikani, CEO, Piramal Alternatives, said the firm is pleased to partner with Kolors as the company enters its next phase of growth. He highlighted Kolors’ established brand, differentiated presence in the wellness and preventive healthcare segment, focus on customer outcomes and continued investment in technology and service innovation.

Vijaya Krishna, MD, Kolors Healthcare India, said the investment represents a strong endorsement of the company’s platform and management team. The capital will enable Kolors to accelerate clinic expansion, strengthen infrastructure, expand its service offerings and advance its Kolors 2.0 transformation, while benefiting from Piramal Alternatives’ institutional expertise and long-term approach.

Venkata Shivaji Kuna, Executive Director, Kolors Healthcare India, said the partnership would help address India’s growing wellness needs through solutions that are accessible, personalised and outcome-driven. Through Kolors 2.0, the company aims to build a stronger wellness platform focused on lifestyle and preventive healthcare requirements across the country.